Drug – bio-affecting and body treating compositions – Extract – body fluid – or cellular material of undetermined... – Body fluid or exudate or transudate other than snake venom,...
Reexamination Certificate
2008-07-22
2008-07-22
Lankford, Jr., Leon B (Department: 1651)
Drug, bio-affecting and body treating compositions
Extract, body fluid, or cellular material of undetermined...
Body fluid or exudate or transudate other than snake venom,...
C424S520000
Reexamination Certificate
active
07402322
ABSTRACT:
The invention relates to the field of immunology. Specifically, the invention relates to the field of immune-mediated disorders such as allergies, auto-immune disease, transplantation-related disease or inflammatory disease. The invention provides for an immunoregulator (IR), use of an IR in preparing a pharmaceutical composition for treating an immune-mediated disorder and a method for treating an immune-mediated disorder.
REFERENCES:
patent: 4330466 (1982-05-01), Yanaihara et al.
patent: 4427660 (1984-01-01), Schiffman et al.
patent: 4571336 (1986-02-01), Houck et al.
patent: 4753965 (1988-06-01), Stemerick et al.
patent: 4855285 (1989-08-01), Stevens
patent: 4977244 (1990-12-01), Muchmore et al.
patent: 5002961 (1991-03-01), Dage et al.
patent: 5055447 (1991-10-01), Palladino et al.
patent: 5223397 (1993-06-01), Pouletty
patent: 5380668 (1995-01-01), Herron
patent: 5436270 (1995-07-01), Wang
patent: 5677275 (1997-10-01), Lunardi-Iskandar et al.
patent: 5700781 (1997-12-01), Harris
patent: 5801193 (1998-09-01), Ojo-Amaize et al.
patent: 5851997 (1998-12-01), Harris
patent: 5854004 (1998-12-01), Czernilofsky et al.
patent: 5856440 (1999-01-01), Wang
patent: 5877148 (1999-03-01), Lunardi-Iskandar et al.
patent: 5942494 (1999-08-01), Ginsberg et al.
patent: 5958413 (1999-09-01), Anagnostopulos et al.
patent: 5966712 (1999-10-01), Sabatini et al.
patent: 5968513 (1999-10-01), Gallo et al.
patent: 5972924 (1999-10-01), Keep et al.
patent: 5981486 (1999-11-01), Matsushima et al.
patent: 5994126 (1999-11-01), Steinman et al.
patent: 5997871 (1999-12-01), Gallo et al.
patent: 6051596 (2000-04-01), Badger
patent: 6075150 (2000-06-01), Wang et al.
patent: 6150500 (2000-11-01), Salerno
patent: 6235281 (2001-05-01), Stenzel et al.
patent: 6278794 (2001-08-01), Parekh et al.
patent: 6310041 (2001-10-01), Haddox et al.
patent: 6319504 (2001-11-01), Gallo et al.
patent: 6361992 (2002-03-01), Szkudlinski et al.
patent: 6379970 (2002-04-01), Liebler et al.
patent: 6416959 (2002-07-01), Giuliano et al.
patent: 6489296 (2002-12-01), Grinnell et al.
patent: 6507788 (2003-01-01), Camara y Ferrer et al.
patent: 6539102 (2003-03-01), Anderson et al.
patent: 6583109 (2003-06-01), Gallo et al.
patent: 6596688 (2003-07-01), Gallo et al.
patent: 6620416 (2003-09-01), Gallo et al.
patent: 6630138 (2003-10-01), Gerlitz et al.
patent: 6711563 (2004-03-01), Koskas
patent: 6727227 (2004-04-01), Khavinson
patent: 6831057 (2004-12-01), Baldwin et al.
patent: 6844315 (2005-01-01), Khan et al.
patent: 6921751 (2005-07-01), Khan et al.
patent: 7175679 (2007-02-01), Khan et al.
patent: 2002/0041871 (2002-04-01), Brudnak
patent: 2002/0064501 (2002-05-01), Khan et al.
patent: 2002/0147306 (2002-10-01), Lin et al.
patent: 2003/0049273 (2003-03-01), Gallo et al.
patent: 2003/0113733 (2003-06-01), Khan et al.
patent: 2003/0119720 (2003-06-01), Khan et al.
patent: 2003/0148955 (2003-08-01), Pluenneke
patent: 2003/0166556 (2003-09-01), Khan et al.
patent: 2003/0186244 (2003-10-01), Margus et al.
patent: 2003/0215434 (2003-11-01), Khan et al.
patent: 2003/0219425 (2003-11-01), Khan et al.
patent: 2003/0220257 (2003-11-01), Benner et al.
patent: 2003/0220258 (2003-11-01), Benner et al.
patent: 2003/0220259 (2003-11-01), Benner et al.
patent: 2003/0220260 (2003-11-01), Khan et al.
patent: 2003/0220261 (2003-11-01), Khan et al.
patent: 2003/0224995 (2003-12-01), Khan et al.
patent: 2004/0013661 (2004-01-01), Wensvoort et al.
patent: 2004/0208885 (2004-10-01), Khan et al.
patent: 2005/0037430 (2005-02-01), Khan et al.
patent: 2005/0107314 (2005-05-01), Gorczynski et al.
patent: 2005/0214943 (2005-09-01), Khan et al.
patent: 2005/0227925 (2005-10-01), Benner et al.
patent: 2006/0111292 (2006-05-01), Khan et al.
patent: 2006/0142205 (2006-06-01), Benner et al.
patent: 3715662 (1987-11-01), None
patent: 19953339 (2001-05-01), None
patent: 1 138 692 (2001-10-01), None
patent: 1 300 418 (2003-04-01), None
patent: 2194886 (1988-03-01), None
patent: 96/04008 (1996-02-01), None
patent: 97/49373 (1997-12-01), None
patent: 97/49418 (1997-12-01), None
patent: 97/49432 (1997-12-01), None
patent: WO 97/49721 (1997-12-01), None
patent: WO 98/34631 (1998-08-01), None
patent: WO 98/35691 (1998-08-01), None
patent: WO 99/59617 (1999-11-01), None
patent: WO 01/10907 (2001-02-01), None
patent: WO 01/11048 (2001-02-01), None
patent: WO 01/29067 (2001-04-01), None
patent: WO 01/68113 (2001-09-01), None
patent: WO 01/72831 (2001-10-01), None
patent: WO 2001/83554 (2001-11-01), None
patent: WO 02/085117 (2002-10-01), None
patent: WO 03/029292 (2003-04-01), None
Dariusz P. Olszyna, Jan M. Prins, Barbara Buis, Sander J. H. Van Deventer, Peter Speelman, and Tom Van Der Poll “Levels of Inhibitors of Tumor Necrosis Factor Alpha and Interleukin 1b in Urine and Sera of Patients with Urosepsis” Infection and Immunity Aug. 1998, p. 3527-3534.
Mark Malyak, Joel M. Guthridge, Kenneth R. Hance, Steven K. Dower,2‡ John H. Freed,†§ and William P. Arend “Characterization of a Low Molecular Weight Isoform of IL-1 Receptor Antagonist” The Journal of Immunology 1998, 161: 1997-2003.
Ohlsson, Kjell; Bjork, Peter; Bergenfeldt, Magnus; Hageman, Robert; Thompson “Interleukin-1 Receptor Antagonist Reduces Mortality from Endotoxin Shock” Nature; Dec. 6, 1990; 348, 6301.
John B. Fassio, E. Brit Brockman, Marcia Jumblatr, Cynfhio Grearoat John L. Henry, “Transforming Growth Factor Alpha and Its Receptor in Neural Retina” Investigative Ophthalmology & Visual Science, vol. 30, No. 9, Sep. 1989.
Erika V. Valore, Christina H. Park, Alison J. Quayle,“Human b-Defensin-1: An Antimicrobial Peptide of Urogenital Tissues” J. Clin. Invest. vol. 101, No. 8, Apr. 1998, 1633-1642.
Evelyn B. Wallraff, Emily C. Brodie, and Alice L. Borden “Urinary Excretion of Amino Acids in Pregnancy” J. Clinc. Invest, 29, 1950: p. 1542-1544.
Ivanov et al., “Hemoglobin as a Source of Endogenous Bioactive Peptides: The Concept of Tissue-Specific Peptide Pool,” Biopolymers, 1997, pp. 171-188, vol. 39.
Khavinson et al, Gerontological Aspects of Genome Peptide Regulation, 2005, S. Karger AG, Basel, Switzerland.
Khavinson et al., “Effects of Livagen Peptide on Chromatin Activation in Lymphocytes from Old People,” Bulletin of Experimental Biology and Medicine, Oct. 2002, pp. 389-392, vol. 134, No. 4.
Khavinson et al., “Effects of Short Peptides on Lymphocyte Chromatin in Senile Subjects,” Bulletin of Experimental Biology and Medicine, Jan. 2004, pp. 78-81, vol. 137, No. 1.
Khavinson et al., “Epithalon Peptide Induces Telomerase Activity and Telomere Elongation in Human Somatic Cells,” Bulletin of Experimental Biology and Medicine, Jun. 2003, pp. 590-592, vol. 135, No. 6.
Khavinson et al., “Inductive Activity of Retinal Peptides,” Bulletin of Experimental Biology and Medicine, Nov. 2002, pp. 482-484, vol. 134, No. 5.
Khavinson et al., “Mechanisms Underlying Geroprotective Effects of Peptides,” Bulletin of Experimental Biology and Medicine, Jan. 2002, pp. 1-5, vol. 133, No. 1.
Khavinson et al., “Peptide Promotes Overcoming of the Division Limit in Human Somatic Cell,” Bulletin of Experimental Biology and Medicine, May 2004, pp. 503-506, vol. 137, No. 5.
Morozov et al., “Natural and Synthetic Thymic Peptides as Therapeutics for Immune Dysfunction,” Int. J. Immunopharmac., 1997, pp. 501-505, vol. 19, No. 9/10.
#PCT International Search Report, PCT/NL01/00259, dated Dec. 18, 2001, 3 pages.
#International Search Report, International Application No. PCT/NL02/00639, mailed Aug. 4, 2003 (8 pages).
#Connelly et al., Biphasic Regulation of NF-κB Activity Underlies the Pro- and Anti-Inflammatory Actions of Nitric Oxide, The Journal of Immunology, 2001, pp. 3873-3881, 166, The American Association of Immunologists, USA.
#Friedlander, Tackling anthrax, Nature, Nov. 8, 2001, pp. 160-161, vol. 414.
#Medzhitov, Toll-like Receptors and Innate Immunity, Nature Reviews/Immunology, Nov. 2001, pp. 135-145,
Benner Robbert
Khan Nisar Ahmed
Savelkoul Hubertus Franciscus Josef
Biotempt B.V.
Lankford, Jr. Leon B
TraskBritt
Underdahl Thane
LandOfFree
Methods of treatment for septic shock with urine extract does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of treatment for septic shock with urine extract, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treatment for septic shock with urine extract will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2744360